RxDoctor Payments Data

Frank Johannes Plate

Adult Reconstructive Orthopaedic Surgery · Pittsburgh, PANPI 1942644406

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 93.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $76,614 and has fallen 64.2% since, to $27,429 in 2025. Among adult reconstructive orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$239,015in general payments, 2019–2025

Across 332 payments — averaging $719.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$223K
  • Total Joint Orthopedics, Inc.$4K
  • Medacta USA, Inc.$3K
  • Medical Device Business Services, Inc.$3K
  • Zimmer Biomet$2K
  • Stryker$1K
  • plus $2K from 6 others
$55,675in research payments, 2019–2025

Across 1 payment — averaging $55,675 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Onkos Surgical, Inc.$56K

What the payments were for

  • Consulting fees$92,77539%
  • Speaking & faculty fees$83,05035%
  • Grants$2,0211%
  • Travel & lodging$36,72115%
  • Food & beverage$16,9487%
  • Education$7,5003%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$239,015 in reported general payments places this provider in the 90th percentile of 51 adult reconstructive orthopaedic surgery providers in Pennsylvania.

See all adult reconstructive orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$166,141
Medicare patients
325
Services billed
6,563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam263$566
Amoxicillin143$216
Oxycodone Hcl32$120
Methylprednisolone17$100
Gabapentin36$48
Cephalexin45$47
Clindamycin Hcl47$47

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →